Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-115736
Filing Date
2024-10-21
Accepted
2024-10-21 06:24:44
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 atha_2024_s-3.htm S-3 421582
2 EX-4.3 atha-ex4_3.htm EX-4.3 559050
3 EX-5.1 atha-ex5_1.htm EX-5.1 35964
4 EX-23.1 atha-ex23_1.htm EX-23.1 3762
5 EX-FILING FEES atha-exfiling_fees.htm EX-FILING FEES 102517
6 GRAPHIC img197651469_0.jpg GRAPHIC 15417
7 GRAPHIC img222338278_0.jpg GRAPHIC 125859
  Complete submission text file 0000950170-24-115736.txt   1318699
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282738 | Film No.: 241381924
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)